was collected during three separate projects in the same hospital. The first cohort included 35 COPD patients admitted for an acute exacerbation to a non-ICU bed to determine if there was a relationship between corticosteroid dosage and hyperglycemia. The second cohort included 210 COPD patients with acute exacerbations who were admitted to the MICU to determine factors associated with mortality and LOS. The third cohort included 105 COPD patients who were monitored for re-admission within 30 days after discharge for an acute exacerbation. This study we included all adult patients with a discharge diagnosis of COPD exacerbation identified by the coders in the Department of Internal Medicine; we excluded patients younger than 18 years and those admitted to an ICU. Data collected included forced expiratory volume in 1 second (FEV1), history of diabetes, blood glucose at admission, peak glucose, and maximum daily dose of corticosteroid. Data collected included the patients' ages, sex, body mass indices (BMI), baseline pulmonary function tests, comorbidities, complete blood counts (CBCs), complete metabolic profiles, albumin levels, initial arterial blood gases, sputum cultures, blood cultures, chest X-rays, Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, confusion, urea, respiratory rate, systolic blood pressure (CURB65) scores, final diagnoses, total duration of hospital stay, and in-hospital mortality. We separated patients into two groups: Group One died during hospitalization and Group Two survived to hospital discharge. The primary outcome in this study was the identification factors associated with increased in-hospital mortality; the secondary outcome was the identification of the factors associated with increased LOS. We separated patients by LOS into four quartiles to identify parameters associated with increased LOS. Descriptive statistics to summarize base line characteristics of patients in all three cohorts. T-tests and Chi square tests were used to analyze differences between patients who died and patients who survived the acute flare. Multivariable logistic regression models were used to determine factors that predicted increased mortality and LOS. T-tests were used to compare highest blood glucose levels in the early re-hospitalization group with the non-early rehospitalization group. Results: Table-I Mean arterial pressure, hemoglobin, blood urea nitrogen, albumin, nursing home, pleural effusion and intubation were statistically significant (p<0.05) between two group.
Table-IV: Factors associated with length of stay in patients admitted to an intensive care unit (ICU).

The Association between Glucose Levels and Hospital Outcomes in Patients
Ahmed, et al. 122±33 mg/dl with a range of 83 to 238 mg/dl. Six patients had maximum glucose levels above 200 mg/dl. Ten patients with diabetes (DM) had mean initial glucose levels of 196±110 mg/dl with a range of 77 to 446 mg/dl, and nine had maximum glucose levels above 200 mg/dl. We stratified the patients into tertiles based on the maximum daily dose of corticosteroids received during hospitalization. There were no differences in the initial or maximum glucose levels in these three groups (P > 0.05) Parappil reviewed 246 episodes of AECOPD 9 . Forty-two percent of the admissions had a random glucose greater than 180 mg/ dl, but mean values were not provided. Fifty-three patients (22%) had DM. Burt measured glucose values in 47 patients using a continuous monitoring system; the mean level was 137±34 mg/dl 10 . The peak levels in their cohort were 220±61 mg/dl. Seven patients (15%) had DM.
Chakrabarti studied 88 patients with decompensated COPD (mean pH = 7.25) who required non-invasive ventilation 11 . Jafar et al. 7 reported only the highest blood glucose recorded for the patients during their hospital stay was used for analysis, and patients were grouped according to their blood glucose quartile (group 1, <108 mg/dl, n = 69; group 2, 108-125 mg/dl, n = 69; group 3, 126-160 mg/dl, n = 75; and group 4, >160 mg/dl, n = 71). The relative risk (RR) of death or a longer inpatient stay was significantly increased in group 3 (RR 1.46, 95% CI 1.05 to 2.02, p = 0.02) and group 4 (RR 1.97, 95% CI 1.33 to 2.92, p<0.0001) compared to group 1. For each 18 mg/dl increase in blood glucose the absolute risk of an adverse outcome increased by 15% (95% CI 4% to 27%, p = 0.006).
In this study observed that the mean arterial pressure, hemoglobin, blood urea nitrogen, albumin, nursing home, pleural effusion and intubation were statistically significant (p<0.05) between two group. Islam et al. 8 reported that the majority of excluded patients had congestive heart failure with exacerbation or acute asthma and did not have an AECOPD as the primary diagnosis. Therefore, this study enrolled 217 cases with AECOPD who needed ICU admission; 26 died during hospitalization and 191 survived to hospital discharge. Eighty-nine percent of the patients who died in the hospital had a FEV1 less than 50% of predicted; 68% of the survivors had a FEV1 less than 50 % of predicted. The mean initial blood glucose on admission in this cohort was 156±74.3 mg/dl (range 60 to 485 mg/dL). The overall LOS was 9.01±6.00 days. It was 8.37±4.99 days in survivors and 13.69±9.78 days in non-survivors. Initial mean blood glucose was 156±74.3 mg/dl and did not predict a statistically significant increased LOS in univariate logistic regression analysis (OR 1.00; 95% CI: 0.99-1.01, P = 0.59). Baker et al. measured glucose levels in 284 patients with acute exacerbations of COPD requiring hospitalization and reported the highest value measured either at admission or during the admission 12 . Glucose levels have a circadian pattern with higher values in the late afternoon in corticosteroid treated patients with AECOPD, and routine morning lab tests may not detect the range of glucose elevations 13, 14 . In addition, glycemic variability is associated with increased length of stay and mortality in hospitalized patients and needs to be considered in these studies 15 . In-hospital management of hyperglycemia is relatively easy and prevents complications 16, 17 . Moretti and colleagues studied 186 patients admitted to a respiratory intensive care unit with respiratory failure characterized by a mean pH of 7.23± 0.07 and a mean PaCO2 of 85.3 ±15.8 mm Hg 18 . Krinsley studied the relationship between hyperglycemia and hospital mortality in a heterogeneous group of critically ill patients and concluded that even modest hyperglycemia after intensive care unit admission was associated with a substantial increase in hospital mortality in patients with a wide range of medical and surgical diagnoses 19 .
In current study reported intubation had 5.318 (95% CI 2.578 to 11.721) times increase in odds having length of stay. Intubation was significantly associated with length of stay. Islam et al. 8 20, 21 . Hyperglycemia causes glycosylation of proteins, impaired leukocyte function, and activation of pro-inflammatory genes through transcription factors 20, 22 . Glycosuria potentially causes an osmotic diuresis with a loss of electrolytes and volume contraction which could adversely affect the clinical course. Occasionally, patients on corticosteroids develop hyperglycemic hyperosmolar syndrome or diabetic ketoacidosis. Other studies have reported that hyperglycemia increases the mortality in patients with acute myocardial infarction, with ischemic or hemorrhagic stroke, and with community-acquired pneumonia 6, 23 . Parappil et al. 9 retrospectively analyzed 172 patients admitted with AECOPD, including 39 patients with comorbid diabetes mellitus. In their study the presence of DM was associated with increased length of stay (mean 7.8 days) and mortality (8%) in comparison with patients without DM (6.5 days and 4% mortality), but these differences were not statistically significant.
In present study observed that patients had 105 admissions, including 14 early rehospitalizations (13.3%), defined as a re-hospitalization within 30 days after discharge. The difference were not statistically significant (p>0.05) between two group. Islam et al. 8 reported these patients had 103 admissions, including 13 early rehospitalizations (12.6 %), defined as a re-hospitalization within 30 days after discharge. The mean peak blood glucose levels were 212±105 mg/dl with a range from 94 mg/dl to 600 mg/dl. There were no differences in mean peak glucose levels between early re-hospitalization and non-early re-hospitalization patients (P = 0.318).
Conclusion:
Mean arterial pressure, hemoglobin, blood urea nitrogen, albumin, nursing home, pleural effusion and intubation were statistically significant between in hospital deaths group and survivors group. On the frequency and severity of hyperglycemia in these patients, the factors associated with hyperglycemia, the effects of hyperglycemia on short term outcomes.
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